Kiyomi Kimura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kiyomi Kimura has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Akiko Ogiya
Department of Breast Surgery, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo, Nagaizumi-cho, Suntou-gun, Shizuoka, 411-8777, Japan,
1 shared publication - Futoshi Akiyama
Division of Pathology, Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
1 shared publication - Hidetomo Morizono
Department of Breast Surgery, Cancer Institute Hospital, Tokyo, Japan
1 shared publication - Keiichiro Tada
Department of Breast Surgery, Cancer Institute Hospital, Tokyo, Japan
1 shared publication - Kotaro Iijima
Department of Breast Surgery, Cancer Institute Hospital, Tokyo, Japan
1 shared publication - Masujiro Makita
Department of Breast Surgery, Cancer Institute Hospital, Tokyo, Japan
1 shared publication
Latest Publications
- Open Access
- 27 January 2010
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 8 (1) , 6
Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer
The impact of sentinel lymph node biopsy on breast cancer mimicking ductal carcinoma in situ (DCIS) is a matter of debate. We studied the rate of occurrence of sentinel lymph node metastasis in 255 breast cancer patients with pure DCIS showing no invasive components on routine pathological examination. We compared this to the rate of occurrence in 177 patients with predominant intraductal-component (IDC) breast cancers containing invasive foci equal to or less than 0.5 cm in size. Most of the clinical and pathological baseline characteristics were the same between the two groups. However, peritumoral lymphatic permeation occurred less often in the pure DCIS group than in the IDC-predominant invasive-lesion group (1.2% vs. 6.8%, p = 0.002). One patient (0.39%) with pure DCIS had two sentinel lymph nodes positive for metastasis. This rate was significantly lower than that in patients with IDC-predominant invasive lesions (6.2%; p < 0.001). Because the rate of sentinel lymph node metastasis in pure DCIS is very low, sentinel lymph node biopsy can safely be omitted.
- 27 January 2010
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 8 (1) , 6
Open AccessDuctal carcinoma in situ and sentinel lymph node metastasis in breast cancer
The impact of sentinel lymph node biopsy on breast cancer mimicking ductal carcinoma in situ (DCIS) is a matter of debate. We studied the rate of occurrence of sentinel lymph node metastasis in 255 breast cancer patients with pure DCIS showing no invasive components on routine pathological examination. We compared this to the rate of occurrence in 177 patients with predominant intraductal-component (IDC) breast cancers containing invasive foci equal to or less than 0.5 cm in size. Most of the clinical and pathological baseline characteristics were the same between the two groups. However, peritumoral lymphatic permeation occurred less often in the pure DCIS group than in the IDC-predominant invasive-lesion group (1.2% vs. 6.8%, p = 0.002). One patient (0.39%) with pure DCIS had two sentinel lymph nodes positive for metastasis. This rate was significantly lower than that in patients with IDC-predominant invasive lesions (6.2%; p < 0.001). Because the rate of sentinel lymph node metastasis in pure DCIS is very low, sentinel lymph node biopsy can safely be omitted.